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Abstract 
Background: Malaria accounts for the largest portion of healthcare demand in Angola. A pillar of malaria control 
in Angola is the appropriate management of malaria illness, including testing of suspect cases with rapid diagnostic 
tests (RDTs) and treatment of confirmed cases with artemisinin-based combination therapy (ACT). Periodic systematic 
evaluations of malaria case management are recommended to measure health facility readiness and adherence to 
national case management guidelines.
Methods: Cross-sectional health facility surveys were performed in low-transmission Huambo and high-transmission 
Uíge Provinces in early 2016. In each province, 45 health facilities were randomly selected from among all public 
health facilities stratified by level of care. Survey teams performed inventories of malaria commodities and conducted 
exit interviews and re-examinations, including RDT testing, of a random selection of all patients completing outpa-
tient consultations. Key health facility readiness and case management indicators were calculated adjusting for the 
cluster sampling design and utilization.
Results: Availability of RDTs or microscopy on the day of the survey was 71% (54–83) in Huambo and 85% (67–94) 
in Uíge. At least one unit dose pack of one formulation of an ACT (usually artemether–lumefantrine) was available in 
83% (66–92) of health facilities in Huambo and 79% (61–90) of health facilities in Uíge. Testing rates of suspect malaria 
cases in Huambo were 30% (23–38) versus 69% (53–81) in Uíge. Overall, 28% (13–49) of patients with uncomplicated 
malaria, as determined during the re-examination, were appropriately treated with an ACT with the correct dose in 
Huambo, compared to 60% (42–75) in Uíge. Incorrect case management of suspect malaria cases was associated with 
lack of healthcare worker training in Huambo and ACT stock-outs in Uíge.
Conclusions: The results reveal important differences between provinces. Despite similar availability of testing and 
ACT, testing and treatment rates were lower in Huambo compared to Uíge. A majority of true malaria cases seeking 
care in health facilities in Huambo were not appropriately treated with anti-malarials, highlighting the importance 
of continued training and supervision of healthcare workers in malaria case management, particularly in areas with 
decreased malaria transmission.
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Background
As in many sub-Saharan African countries, febrile illness 
is the single largest cause of healthcare seeking in Angola, 
responsible for 35% of outpatient visits and 20% of all 
inpatient services in public health facilities [1]. Much of 
the febrile illness can be attributed to malaria, as a sub-
stantial proportion of Angolans are infected with malar-
ial parasites at any given time, measured to be 13.5% in 
children under five in 2015–2016 [2, 3]. The entire coun-
try is endemic for malaria, although there is heterogene-
ity in malaria transmission, ranging from low, seasonal, 
epidemic-prone transmission in the dry south to high, 
year-round transmission in the wet, tropical north of 
the country. Despite having made substantial progress in 
rolling out malaria control interventions since the mid-
2000s, there has been an increase in malaria cases in 
Angola in 2015 and 2016 as seen in routine data collected 
by the Angola National Malaria Control Programme 
(NMCP), with a concurrent increase in malaria mortality. 
Thus, ensuring appropriate diagnosis and treatment for 
malaria is a critical health priority in Angola.
The strategy to reduce the malaria burden in Angola 
has two primary components: the reduction of malaria 
incidence through prevention activities, including vector 
control, and prompt diagnosis and appropriate treatment 
of acute malaria cases [1]. Angola has adopted World 
Health Organization (WHO) recommendations for 
malaria case management. Artemisinin-based combina-
tion therapy (ACT) was introduced as first-line treatment 
for uncomplicated malaria in 2006. In 2009, the coun-
try adopted a policy of universal laboratory confirma-
tion for all suspect malaria cases either with microscopy, 
restricted primarily to hospitals and health centres, or 
rapid diagnostic tests (RDTs), used at all levels. The three 
ACT currently in use for first-line treatment in Angola 
are artemether-lumefantrine, artesunate–amodiaquine 
and dihydroartemisinin–piperaquine. Pregnant women 
in the first trimester are treated with oral quinine. Severe 
malaria cases are treated, in order of preference, with 
intravenous artesunate, intramuscular artemether or 
intravenous quinine.
Provision of appropriate care for an acute malaria case 
is a multi-step process that can be divided into four con-
secutive steps [4]: the ill person must seek care (access), 
be treated appropriately by a healthcare provider com-
plying with national treatment guidelines (compliance), 
adhere to the prescribed treatment (adherence), and 
respond appropriately to the treatment (efficacy). The 
coverage at each step can be estimated separately from 
multiple sources, and the overall effective coverage can 
be calculated as the product of the coverage at each step. 
Community-based surveys can provide estimates for the 
access and adherence steps, and data from anti-malarial 
resistance monitoring provide estimates of anti-malarial 
efficacy.
Perhaps the most difficult step to assess is the com-
pliance step, where appropriate case management of 
malaria cases is provided at health facilities. Its imple-
mentation is a complex undertaking that requires the 
confluence of several key activities. Firstly, health facili-
ties must have all the necessary commodities to diagnose 
and treat malaria, including a sufficient and continu-
ous supply of quality-assured malaria tests, reagents 
for microscopy when applicable, and appropriate anti-
malarials. Next, sufficient numbers of healthcare workers 
(HCWs) need to be trained in malaria case management, 
including use of RDTs, treatment, and when applicable, 
malaria microscopy. Next, HCWs need to be routinely 
supervised to ensure ongoing quality of service delivery 
and adherence to national treatment guidelines. Finally, 
accurate data on suspected and confirmed cases of 
malaria must be recorded and reported onward to ensure 
that decisions about malaria prevention and treatment 
can be targeted where they will have the greatest impact.
Assessment of the compliance step cannot be done 
from community-based surveys and necessitates col-
lection of individual data at the health-facility level to 
characterize HCW performance for each of the steps in 
the case-management pathway. Evaluations in the form 
of systematic health facility surveys are a useful tool for 
monitoring the functioning of the different components 
of malaria case management implementation, especially 
in the context of changing malaria incidence and policies 
[5–7]. The Angola NMCP and the US President’s Malaria 
Initiative (PMI) conducted a malaria-specific health facil-
ity survey in the central province of Huambo in 2007, 
coinciding with the start of PMI support in the country. 
Serving as a baseline, the survey found overall poor prac-
tices by HCWs with substantial weaknesses in testing and 
treatment practices [8].
In early 2016, the Angola NMCP implemented a subse-
quent, malaria-focused health facility survey in Huambo 
Province, the site of the 2007 survey, and in Uíge Prov-
ince, a PMI-supported province in the north of the coun-
try. The objective was to assess health facility readiness 
for malaria diagnosis and treatment and to evaluate the 
quality of malaria case management.
Methods
A cross-sectional survey of health facilities was inde-
pendently carried out in two provinces (Fig. 1): Huambo 
Province with meso-endemic-stable malaria transmis-
sion in the central highlands of Angola and Uíge Province 
with hyperendemic malaria transmission in northern 
Angola, an area covered with grassland savannahs inter-
spersed with dense tropical forest. The survey took place 
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in February 2016, at the peak of malaria transmission 
season in both provinces.
In each province, an exhaustive list of all public health 
facilities was obtained from the Provincial Directorate of 
Health, encompassing 230 health facilities in Huambo 
and 321 in Uíge. A total of 45 health facilities were ran-
domly selected in each province, stratifying by health 
facility classification: nine hospitals, 18 health centres 
and 18 health posts. In each health facility, a maximum 
of five HCWs present during the visit were purposively 
chosen for interviews based on malaria case manage-
ment workload. Additionally, a maximum of 20 patients 
were randomly invited to be interviewed and undergo a 
re-examination by a study clinician. All patients attend-
ing the outpatient department on the day of the visit were 
eligible for inclusion in the survey, independent of demo-
graphics or symptoms. The number of outpatient visits 
1 week prior to the visit was abstracted from the health 
facility register, a sampling interval was determined, and 
randomly selected patients were invited to participate 
as they arrived. If the health facility saw fewer than 20 
patients, all patients were invited to take part. In health 
facilities with separate paediatric and adult outpatient 
clinics, ten patients were chosen from each clinic.
The survey was powered to obtain a point estimate of 
the proportion of patients with an acute malaria episode 
treated with a first-line anti-malarial with a 95% confi-
dence interval precision of 10%. Estimating that 40% of 
all patients would be suspect malaria cases, and assuming 
a 44% test positivity rate estimated from routine health 
facility data, a 75% treatment rate and a design effect of 
2, the target sample size was calculated to be 820 patients 
per province.
Data collection
In each province, four survey teams, each composed of 
a national-level supervisor and three interviewers, visited 
selected health facilities. The teams spent a full work-
day in each health facility, with data collection lasting 
3 weeks per province. Survey teams carried out three pri-
mary activities: interviews with HCWs and facility direc-
tors; exit interviews and re-examinations of patients; 
and an inventory of 16 malaria commodities. Interviews 
were conducted using standardized questionnaires. Dur-
ing interviews with HCWs, interviewers enquired about 
HCW training, supervision and access to guidelines and 
job-aids.
Selected patients agreeing to participate in the survey 
were given a study identification card upon arrival at the 
health facility and were asked to present to the survey 
team once they completed their consultation and prior 
to leaving the health facility. During the exit interviews, 
interviewers asked about the history and symptoms of 
the current illness and asked patients to recall whether 
they were asked about fever by the HCW, whether they 
were tested for malaria during the consultation, what 
treatments they were prescribed, and what counsel-
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Fig. 1 Location of health facilities visited during health facility surveys in Angola, 2016
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and treatment were verified through examination of any 
available patient cards and prescriptions and any drugs 
that were dispensed at the health facility. For the re-
examination, survey teams took patient temperatures, 
performed an RDT (SD Bioline P. falciparum/P. vivax, 
Yongin, Republic of Korea), and provided artemether-
lumefantrine, supplied by the Angolan NMCP, dosed 
according to weight, for RDT-positive patients that had 
not been prescribed appropriate anti-malarial treatment 
at the health facility.
At the end of the health facility visit, survey teams 
abstracted data from the health facility register for the 
selected patients and recorded the total number of out-
patient visits during the day of the visit. All data collec-
tion was done on electronic tablets using SurveyCTO 
software (Dobility, Cambridge, USA).
Variable definitions
Key health facility readiness indicators [9], including 
availability of key malaria commodities and HCW train-
ing and supervision, were calculated separately for each 
province. For each of the 16 malaria commodities, the 
proportion of health facilities managing each commodity 
(defined as regularly receiving and using the commod-
ity) and the proportion stocked out on the day of visit 
(excluding expired commodities), were calculated. Any 
HCW that reported attending any malaria case man-
agement training was counted as having been trained in 
malaria case management.
Standard indicators for malaria case management [9], 
including the testing rate of suspect cases and treatment 
rate of confirmed cases, were calculated separately for 
each province. A suspect malaria case was defined as a 
patient complaining of fever or history of fever in the last 
24  h, as recorded during the exit interview, or a with a 
temperature above 37.5 °C measured during the re-exam-
ination. A true case was defined as a suspect malaria case 
testing RDT-positive during the exit interview. Con-
firmed cases were defined as laboratory-confirmed cases 
based on testing by health facility staff that also tested 
RDT-positive during the exit interview. Correct manage-
ment of a suspect malaria case was defined as testing by 
either RDT or microscopy at the health facility, and treat-
ment with or prescription of a first-line anti-malarial 
with the correct dose only among patients testing posi-
tive during the re-examination (true positives). Patients 
with symptoms of severe malaria or general danger signs 
were excluded from the analysis.
The four key steps in the case-management pathway 
were evaluated separately to determine HCW perfor-
mance: the proportion of patients who were asked about 
fever, spontaneously complained of fever, or had their 
temperature taken; the proportion tested by RDT or 
microscopy; the proportion treated or prescribed a first-
line anti-malarial; and, the proportion receiving or pre-
scribed the correct dose. To identify potential gaps in the 
case-management pathway for true malaria cases, the 
proportion of patients correctly managed at each step in 
the pathway was calculated, as was the cumulative pro-
portion of patients correctly managed up to, and includ-
ing, each step in the pathway.
For patients prescribed or given an ACT by the HCW, 
the quality of counselling provided by the HCW was 
assessed. Patients were asked to recall what instructions 
were given by the HCW regarding how to administer the 
ACT and under what circumstances they should return 
to the health facility. Patients were also asked to recite 
the dosing schedule for the prescribed ACT, including 
the number of tablets per dose, the number of doses per 
day, and the total number of days of therapy.
Analysis
Health facility-level indicators were estimated adjusting 
by weighting by the inverse of the probability of health 
facility selection, and patient-level indicators were esti-
mated adjusting by weighting by the inverse of the prod-
uct of the probability of health facility selection and the 
probability of patient selection to adjust for utilization, 
using the R survey package [10].
Logistic regression was used to explore the relationship 
between a suspect malaria case being correctly managed 
and health facility type, availability of ACT and RDTs or 
microscopy, proportion of HCWs in the health facility 
trained in malaria case management, and the propor-
tion of HCWs supervised in the last 6  months. Gender 
and age of the patient and the proportion of patients at 
the health facility testing positive for malaria during the 
re-examination (a measure of local malaria endemicity) 
were included as potential confounders.
Spatial heatmaps generated with Gaussian kernel 
smoothing were created for each province for six indica-
tors: the proportion of patients with malaria, as deter-
mined during the re-examination; the proportion of 
suspect malaria cases correctly managed; the proportion 
of HCWs supervised in the last 6 months; the proportion 
of HCWs trained in malaria case management; the pro-
portion of health facilities with ACT available; and the 
proportion of health facilities with RDTs or microscopy 
available.
All statistical analysis was done in R version 3.3.0 (R 
Foundation for Statistical Computing, Vienna, Austria).
Ethical considerations
The survey was classified as a non-research, programme 
evaluation activity by Human Subjects Review Boards at 
the US Centers for Disease Control and Prevention and 
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the Angolan Ministry of Health. All interviewed patients 
provided written informed consent.
Results
Teams visited 89 out of 90 chosen health facilities, as one 
selected health facility in Huambo no longer existed, rep-
resenting an error in the list provided. The final break-
down by health facility type (Table 1) did not match the 
sampling strategy since several health facilities in each 
province were misclassified on the lists provided by the 
provinces.
Availability of malaria tests and treatments on the 
day of the visit was similar in both provinces, with 71% 
(95% CI 54–83) of health facilities in Huambo and 85% 
(67–94) in Uíge with access to RDTs or microscopy, and 
83% (66–92) of health facilities in Huambo and 79% 
(61–90) in Uíge with access to at least one formulation 
of an unexpired ACT in at least one unit dose package 
format (Table 2). However, stock-out rates of age-specific 
formulations were high in both provinces, ranging from 
29 to 81% for artemether-lumefantrine, and 25 to 100%, 
skewed towards 100%, for artesunate-amodiaquine and 
dihydroartemisinin-piperaquine, which were only man-
aged in a small subset of health facilities (see Additional 
file  1: Table S1). Availability of malaria commodities 
other than ACT and RDTs, such as severe malaria treat-
ment, was also generally low in both provinces, with 
stock-out rates ranging from 25 to 100% (see Additional 
File 1: Table S1).
A total of 119 HCWs were interviewed in Huambo and 
93 in Uíge. Over 90% of health facilities in both provinces 
reported having at least one HCW trained in malaria case 
management and RDT use; 81% (73–87) of HCWs inter-
viewed in Huambo and 80%  (69–89) in Uíge reported 
receiving malaria case management training. In Huambo, 
58% (49–68) of HCWs interviewed reported receiving a 
supervisory visit in the last 6 months, compared to 69% 
(52–83) in Uíge. Only 24% (15–36) of health facilities in 
Huambo and 4% (2–9) in Uíge reported having a trained 
microscopist (Table 2).
In Huambo, 590 patients were interviewed, with 360 
(61%) meeting the criteria of a suspect malaria case 
(Table 1). In Uíge, 430 of 634 (68%) interviewed patients 
were suspect malaria cases. In Huambo, 14% (9–23) of 
suspect malaria cases were true malaria cases (tested 
positive by RDT during the re-examination), compared 
to 53% (45–60) in Uíge.
Among suspect malaria cases, only 30% (23–38) 
were tested by RDT or microscopy in Huambo, com-
pared to 69% (53–81) in Uíge (Table  3). An additional 
9% (6–14) of patients not meeting the suspect malaria 
case definition were tested in Huambo, increasing to 
56% (39–72) in Uíge. In both provinces, testing with 
RDTs was substantially more common than micros-
copy. Patients undergoing testing at the health facility 
who were confirmed to have a positive RDT during the 
Table 1 Numbers and  characteristics of  health facilities, 
healthcare workers, and  patients surveyed in  Huambo 
and Uige Provinces, Angola, 2016
a Defined as RDT-positive during survey re-examination
n (%)
Huambo Uíge Total
Health facility 44 45 89
 Hospital 8 (19) 9 (20) 17 (19)
 Health centre 15 (35) 17 (38) 32 (36)
 Health post 20 (47) 19 (42) 39 (44)
Healthcare workers interviewed 119 93 212
Patients interviewed 590 634 1224
 <5 Years 222 (38) 162 (26) 384 (31)
 5–15 Years 84 (14) 141 (22) 225 (18)
 >15 Years 284 (48) 331 (52) 615 (50)
 Female 367 (62) 396 (62) 763 (62)
 Suspect malaria cases 360 (61) 430 (68) 790 (65)
 True malaria  casesa 51 (9) 242 (38) 293 (24)
Table 2 Standard key indicators on  health facility readi-
ness for malaria care delivery, as assessed in health facility 
surveys in Huambo and Uíge Provinces, Angola, 2016
RDT rapid diagnostic test, ACT artemisinin-based combination therapy, HCW 
healthcare worker
a Confidence intervals undefined
Huambo Uíge
% 95% CI % 95% CI
Health facilities
 Offering any malaria diagnostic services 94 79–99 100 a
  RDT 94 79–99 100 a
  Malaria microscopy 21 12–33 4.5 2–9
 Offering any malaria treatment 100 a 100 a
 With RDT or malaria microscopy available 
on day of visit
71 54–83 85 67–94
 With any formulation of ACT available on 
day of visit
83 66–92 79 61–90
 With at least one HCW trained on RDT 
use
95 78–99 90 73–97
 With at least one HCW trained on malaria 
microscopy
24 15–36 4.5 2–9
 With at least one HCW trained on malaria 
treatment
99 96–100 98 93–99
 With guidelines for diagnosis and treat-
ment of malaria
96 90–98 51 34–68
HCWs trained in malaria case manage-
ment
81 73–87 80 69–89
HCWs supervised in last 6 months 58 49–68 69 52–83
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re-examination were likely to have been treated with 
a first-line anti-malarial, with treatment rates of 74% 
(52–88) in Huambo and 86% (74–93) in Uíge. A minority 
(2% in each province) of patients that had been tested at 
the health facility and were negative by RDT during the 
reexamination received anti-malarial treatment at the 
health facility. Overall, 27% (21–35) of suspect malaria 
cases were tested and were treated according to the test 
result in Huambo, compared to 59% (43–74) in Uíge. 
Among suspect malaria cases testing positive during the 
re-examination (true malaria cases), only 28% (13–49) 
had been given or prescribed a first-line anti-malarial 
with the correct dose in Huambo, compared to 60% (42–
75) in Uíge.
Analysis of the case-management pathway in these true 
malaria cases reveals that in Huambo the step least likely 
to happen was diagnostic testing. This step accounted for 
an overwhelming contribution to incorrect case man-
agement, with 57% of patients falling out of the correct 
case-management pathway at the testing step (Fig. 2). In 
contrast, in Uíge, performance along the entire pathway 
was more uniform, with each step being performed at a 
rate ranging from 76 to 96%.
In Huambo, the proportion of HCWs at the health 
facility reporting having received training in malaria case 
management was the only factor significantly associ-
ated with correct management of suspect malaria cases 
(adjusted OR: 2.7, 95% CI 1–8) (Table 4). Notably, correct 
malaria case management was not significantly associ-
ated with ACT or RDT availability. In contrast, in Uíge, 
availability of ACT was the strongest predictor of correct 
management of suspect malaria cases (adjusted OR: 7.2, 
95% CI 3–20). HCWs were also more likely to manage 
suspect malaria cases incorrectly in older age categories 
in Uíge. In both provinces the majority of incorrect man-
agement of suspect cases of malaria (61% in Huambo and 
73% in Uíge) took place in health facilities where both 
malaria testing and ACT were available.
A high proportion (above 85%) of patients prescribed 
an ACT in either province were instructed by the HCW 
on how to take the ACT and were able to correctly recite 
the dosing schedule (Table  5). However, the first dose 
of ACT was given at the health facility only 4% (95% 
CI 1–15) of the time in Huambo versus 45% (22–70) 
in Uíge. The HCW explained how to take artemether-
lumefantrine, the most commonly prescribed ACT, with 
food only 34% (15–59) of the time in Huambo and 19% 
(11–31) of the time in Uíge. Less than half of all patients 
prescribed an ACT in both provinces reported being 
instructed to return to the health facility if the symptoms 
worsened or did not improve.
There was substantial spatial heterogeneity in the pro-
portion of patients presenting with malaria in both prov-
inces, indicative of underlying spatial variation in malaria 
transmission (see Additional File 1: Figure S1, S2). There 
was also substantial heterogeneity in the performance 
on malaria indicators. In Uíge, the northeast of the prov-
ince exhibiting very high malaria positivity also had the 
highest rates of ACT and RDT stock-outs, and the lowest 
rates of supervision and training.
Table 3 Standard key indicators on healthcare worker performance in malaria case management, as assessed in health 
facility surveys in Huambo and Uíge Provinces, Angola, 2016
RDT rapid diagnostic test
a During re-examination
b Tested and treated with first-line anti-malarial with correct dose only if positive
c Treated with first-line anti-malarial with correct dose
Huambo Uíge
% 95% CI % 95% CI
Suspect malaria cases receiving malaria test 30 23–38 69 53–81
 <5 Years 30 23–38 82 65–92
  RDT 25 18–33 81 64–91
  Microscopy 5 2–13 1 0.2–4
 ≥5 Years 30 21–41 64 46–78
  RDT 28 19–39 63 46–78
  Microscopy 3 1–10 1 0.2–2
Confirmed malaria cases treated with appropriate anti-malarial 74 52–88 86 74–93
Suspect malaria cases negative for  malariaa but treated with anti-malarial 2 0.4–5.6 2 0.7–6.8
Suspect malaria cases not tested and treated with appropriate anti-malarial 1 0.3–4 7 2–23
Suspect malaria cases managed  correctlyb 27 21–35 59 43–74
True malaria cases appropriately  treatedc 28 13–49 60 42–75




Asked about fever or took 
temperature Yes: 96% No: 4%
50 (96%) 1 (4%)
Yes: 41% No: 59%
26 (39%) 24 (57%)
Tested by RDT or 
microscopy
Yes: 74%
19 (27%) 5 (10%)
2 missing 
informaon
Treated or prescribed 
appropriate anmalarial
Yes: 91%
18 (25%) 1 (2%)









Asked about fever or took 
temperature Yes: 96% No: 4%
233 (96%) 9 (4%)
Yes: 76% No: 24%
186 (73%) 47 (23%)
Tested by RDT or 
microscopy
Yes: 86%
157 (63%) 26 (10%)
3 missing 
informaon
Treated or prescribed 
appropriate anmalarial
Yes: 89%
130 (56%) 27 (7%)
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Uíge
Fig. 2 Healthcare worker performance for each step of the case-management pathway in acute malaria cases attending health facilities in Huambo 
and Uíge Provinces, Angola, 2016. Percentages in boxes outlined in dashed lines reflect cumulative proportion of patients managed correctly to that 
point. Boxes outlined in bold represent final categorization and percentages refer to final proportion of cases falling into each final categorization. All 
percentages are adjusted for cluster-sampling design
Table 4 Factors associated with  correct management of  suspect malaria cases attending health facilities in  Huambo 
and Uíge Provinces, Angola, 2016
RDT rapid diagnostic test, ACT artemisinin-based combination therapy, HCW healthcare worker
Variable Huambo Uíge
Adjusted odds ratio 95% CI Adjusted odds ratio 95% CI
Patient age
 <5 Years Ref – Ref –
 5–15 Years 0.86 0.4–2 0.68 0.4–1
 >15 Years 1.3 0.7–2 0.4 0.2–0.7
Patient sex
 Female Ref – Ref –
 Male 0.89 0.5–1 0.66 0.4–1
Health facility type
 Hospital Ref – Ref –
 Health centre 1.2 0.6–2 1.6 0.9–3
 Health post 0.71 0.4–1 1.0 0.6–2
RDT or microscopy available on day of visit 1.7 0.7–5 2.5 1–7
ACT available on day of visit 0.55 0.3–1 7.2 3–20
Proportion of interviewed HCWs supervised in last 6 months 0.69 0.3–1 1.2 0.6–2
Proportion of interviewed HCWs trained in malaria case management 2.7 1–8 1.4 0.6–4
Proportion of patients testing true positive by RDT during re-examination 1.9 0.3–10 0.67 0.2–2
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Discussion
The assessment revealed stark differences in the state of 
malaria case management in the two provinces. Over 
two-thirds of patients presenting with acute malaria 
infection in Huambo left the health facility without hav-
ing been given or prescribed an appropriate anti-malar-
ial. The poor performance of Huambo HCWs manifested 
in very low testing rates, with 30% of all febrile patients 
undergoing a laboratory diagnostic test for malaria, 
showing no improvement over the 31% testing rate meas-
ured in 2007 [8], despite the introduction and expansion 
of RDTs in the intervening time.
Despite an immense increase in RDT and ACT avail-
ability in sub-Saharan Africa in recent years, the over-
all proportion of malaria cases appropriately treated 
with anti-malarials is still low across the continent [11]. 
Although access to healthcare is an important factor, 
errors in malaria case management continue to be a major 
factor in the low population coverage. Commonly, the 
testing step in the case-management pathway is the main 
determinant of overall quality [12–15], and the results of 
this survey are no exception. The change to a policy of uni-
versal confirmation of suspected cases of malaria, made 
possible by the large-scale introduction of RDTs, has had 
a complex and variable effect on prescribing practices. In 
some settings, anti-malarial prescriptions have increased 
while in others it has decreased following the expansion of 
malaria testing [16]. In Huambo, for which two time points 
are available, 43% of true malaria cases that were not 
tested were still diagnosed with malaria (clinical diagnosis) 
in 2007. However, in 2016, empiric treatment with anti-
malarials of suspect cases that were not tested was only 
1%. Treatment of test-negative patients decreased from 
60% in 2007 to 2% in 2016. However, because testing rates 
were measured to only be 30% in 2016, most true malaria 
cases were not treated with an ACT in Huambo, compared 
to a 49% rate of correct treatment of true malaria cases in 
2007. This overall decrease in correct treatment of true 
malaria cases is a cautionary sign that the withdrawal of 
empiric treatment of malaria must be accompanied by a 
sustained effort to attain high testing rates [17].
In contrast to Huambo, malaria case management in 
Uíge was found to be relatively well functioning, with 
HCW performance at each step in the testing and treat-
ment pathway above 75%. However, even with high 
performance at each individual step, overall effective cov-
erage was low. Ultimately, only 56% of all malaria cases 
were correctly managed at all steps, an example of how 
overall low effective coverage can arise despite high cov-
erage at individual steps in the context of interventions 
that require multiple sequential steps to be performed 
correctly [18]. Because there is currently no redundancy 
built into the system, for example in the form of empiric 
treatment, effective coverage will always be driven by the 
weakest steps in the case-management pathway.
The divergence of the two provinces should be inter-
preted in the context of historical malaria epidemiology 
in the two areas. Despite being in the highlands with 
moderate rainfall, Huambo routinely reported among the 
highest rates of malaria in any Angolan province in the 
last decade. As recently as 2010, Huambo reported over 
500,000 annual cases of malaria [19]. However, by 2013, 
case numbers had fallen to just over 40,000 annual cases, 
12% of the 2010 total, following intense vector control 
interventions and the scale-up of modern malaria con-
trol. This was reflected in the fact that only 51 malaria 
cases were identified out of 590 interviewed patients. 
This dramatic reduction in malaria cases might have 
caused a sense of complacency in HCWs in Huambo, 
removing suspicion of malaria and explaining the low 
observed testing rate. However, there are still pockets in 
Huambo with substantial numbers of malaria cases, par-
ticularly in the northeast corner of the province.
Appropriateness of case management of suspect 
malaria cases in Huambo was found to be associated with 
the proportion of HCWs trained in malaria case manage-
ment at the health facility, which suggests that an effort 
to increase the total number of HCWs trained in malaria 
case management should improve this particular indica-
tor. However, given the already high percentage of HCWs 
reporting being trained in malaria case management 
(81%), there is little room for this strategy to increase the 
Table 5 Quality of  counselling in  patients prescribed an 
ACT as  assessed during  exit interviews in  health facility 
surveys in Huambo and Uíge Provinces, Angola, 2016
ACT artemisinin-based combination therapy, AL artemether-lumefantrine, DP 
dihydroartemisinin-piperaquine
a Correct number of tablets per dose, doses per day, and total duration of 
treatment. Calculated only for subset of patients prescribed the correct dose
Huambo Uíge
% 95% CI % 95% CI
Given first dose at health facility 4 0.8–15 45 22–70
Given instructions on how to take ACT 85 57–96 89 76–96
Able to correctly recite dosing  schedulea 90 78–96 85 77–91
Received instructions to
 Take with food
  AL 34 15–59 19 11–31
  DP 29 12–56 98 88–100
 Take on empty stomach
  AL 3 0.6–13 7 4–14
  DP 29 12–56 0 –
 Complete all doses 72 51–86 58 41–74
 Return if worse 44 25–64 26 15–40
 Return if no improvement 38 21–58 31 20–44
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rate of correct management. Improving ACT and RDT 
availability will also not completely address the root of 
the problem, as evidenced by the finding that most incor-
rect management of cases occurred in health facilities 
that had ACT and testing facilities available. Only an 
intervention that can change the mindset of HCWs to 
enforce the need to rule out malaria in all patients pre-
senting with fever would be expected to substantially 
improve the overall outcome, since the decision to use 
available test kits was the weakest step in the process.
Uíge, in contrast to Huambo, has been reporting a rela-
tively steady number of malaria cases to the NMCP over 
the last 5 years, approximately 150,000–250,000 cases per 
year, with no clear year-to-year trend. A different climate 
and economic situation have made malaria transmission 
in Uíge more recalcitrant than in Huambo, evidenced by 
the much larger proportion of malaria infections among 
interviewed patients. The survey suggests that HCWs in 
Uíge are largely cognizant of the role of malaria in the ill 
population they serve, with testing rates of suspect cases 
reaching 77%. Nevertheless, the weakest step in the case-
management pathway was the diagnostic testing step. 
Since inappropriate case management was found to be 
associated with ACT stock-outs, improving the availability 
of malaria commodities should likely improve malaria care 
delivery. Nevertheless, this might prove challenging due to 
the inaccessibility of certain areas in the province. Certain 
health facilities were only reached after 16-h drives, with 
flooded, muddy and sandy roads hampering access. Nota-
bly, health facilities in the difficult-to-reach northeast of 
the province where the proportion of malaria cases was 
the highest were also the ones least likely to have ACT or 
RDTs on hand, or be staffed by HCWs trained in malaria 
case management or routinely supervised. Extra effort is 
needed to focus on areas with this profile to provide qual-
ity malaria care where it is most needed.
In both provinces, HCWs were generally effective in 
explaining the ACT dosing schedule to patients. How-
ever, only a minority of patients were instructed to take 
artemether-lumefantrine with food (34% in Huambo and 
19% in Uíge). Artemether-lumefantrine should be admin-
istered with fatty foods to aid in absorption, and inappro-
priate administration of artemether-lumefantrine might 
lead to lower blood drug levels and increase the risk of 
treatment failure [20]. The importance of counselling 
patients to take artemether-lumefantrine with fatty foods 
should be emphasized in HCW training.
This survey was limited to some extent by a lower than 
expected sample size, having achieved only 75% of its tar-
get sample size. This was driven primarily by low patient 
flow in certain health facilities, particularly lower-level 
health facilities. As a result the overall average num-
ber of patients enrolled per health facility was 14 versus 
the expected 20. While the design effect for the indica-
tor driving the sample size calculation, the proportion 
of patients with an acute malaria episode treated with a 
first-line anti-malarial, was 1.7 in Huambo, it was 10 in 
Uíge, substantially higher than the expected value of 2, 
and a major contributor to the large confidence intervals 
around the case management indicators in Uíge. More-
over, in Huambo, the low test positivity rate resulted in 
only 51 true malaria cases, reducing the precision of the 
survey’s estimates of certain case management indica-
tors. Another limitation to the study was the choice of an 
exit interview strategy, which while accurate for indica-
tors related to procedures such as RDT testing, can be 
less accurate for indicators related to counselling [21, 22].
This health facility survey was carried out during a 
difficult moment for malaria control in Angola. The fall 
in the price of oil and subsequent financial crisis coin-
ciding with the loss of donor support from The Global 
Fund to Fight AIDS, Tuberculosis and Malaria (Global 
Fund) resulted in a weakening of malaria control efforts 
throughout Angola, starting in 2014 and continuing 
into 2016. Recent years have seen routine stock-outs of 
ACT and RDTs throughout Angola. This survey was per-
formed shortly after an emergency shipment of malaria 
commodities from the Global Fund, and the ACT and 
RDT levels reported are likely not representative of their 
availability throughout the year. Yet, even during this 
survey, the stock-out rates of individual formulations of 
ACT were high, making treatment of different age cat-
egories even more difficult for HCWs.
In contrast to other sub-Saharan African countries 
reporting increases in malaria cases in recent years, 
Angola’s increase in morbidity has been accompanied by 
an increase in malaria mortality [19], likely aggravated 
by a yellow fever epidemic. Although this survey was 
not designed to examine clinical management of severe 
malaria cases, delayed or inappropriate management of 
uncomplicated malaria cases increases the likelihood of 
progression to severe disease and higher risk for malaria 
mortality. Moreover, the low availability of intravenous 
artesunate and intramuscular artemether means that 
most severe malaria cases are unlikely to be treated with 
the first-line therapies in Angola.
Conclusion
Improvement of malaria case management is crucial to 
mitigate the effects of the current increase in malaria 
transmission in Angola. The results from this survey con-
firm modelling estimates that the vast majority of acute 
malaria episodes in Angola are not treated with appro-
priate anti-malarial therapy [11]. A main factor is low 
access to the formal healthcare sector, estimated to be 
45% nationwide [1]; this could be mitigated by increasing 
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the numbers of functional health centres or by estab-
lishing a programme for integrated community case 
management of childhood illness. However, the results 
reported here show that poor malaria case management 
at health facilities also contributes to the overall low cov-
erage. The availability of malaria commodities and rates 
of appropriate treatment of the minority of malaria cases 
that do seek care in health facilities must be improved to 
decrease malaria morbidity and mortality in Angola.
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